Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study

Completed · Not applicable

Conditions studied: Primary Malignant Neoplasm of Lung, Primary Malignant Neoplasm of Gastrointestinal Tract

In brief

To assess the feasibility of a creative writing intervention in an advanced cancer population. Given it is a relatively simple intervention delivered by a non-clinician, the investigators are interested in better understanding its pattern of effect on patient psychological adjustment. The investigators aim to assess its feasibility in this study in order to inform a future larger study that will utilize a control arm.

Key facts

Study ID

NCT02575898

Run by

Dartmouth-Hitchcock Medical Center

People needed

23

Starts

2016-01-14

Expected to finish

2018-09-04

Last updated by the study team

2018-11-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant must plan to receive follow up care at Dartmouth-Hitchcock.
• Participant must have a lung or GI primary cancer diagnosed in the last 3 months.
• Participant must have non-curable cancer as judged by the primary oncologist.
• Participant must be comfortable conversing in English (reading and writing in English is not required).
• Participant must be cognitively intact as judged by their responsible clinician.
• Participant must have access to a working telephone and be willing and available to participate by this modality as needed.
• Participants may be on anti-depressants and/or anxiolytics as long as the dosing has remained stable over the preceding 2 weeks.

You may not qualify if…

• Participant is expected to die in 6 months or less as judged by the responsible clinician.
• Participant must not have already worked with the staff writer at Dartmouth Hitchcock prior to enrollment in this study.
• Participant with an activated durable power of attorney for health care or cognitive impairment that interferes with ability to understand prognosis as determined by the primary oncologist.
• Participant must not have uncontrolled physical symptoms.

Where it is running

• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.